Jane Street’s Vaxcyte PCVX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$372K Sell
6,401
-246,476
-97% -$13.4M ﹤0.01% 8703
2026
Q1
$14.7M Sell
252,877
-26,727
-10% -$1.45M ﹤0.01% 2084
2025
Q4
$12.9M Sell
279,604
-64,093
-19% -$2.87M ﹤0.01% 2025
2025
Q3
$12.4M Buy
343,697
+45,949
+15% +$1.52M ﹤0.01% 2154
2025
Q2
$9.68M Buy
297,748
+152,359
+105% +$4.99M ﹤0.01% 2190
2025
Q1
$5.49M Sell
145,389
-153,903
-51% -$12.3M ﹤0.01% 2803
2024
Q4
$24.5M Buy
299,292
+213,749
+250% +$21.2M 0.01% 1124
2024
Q3
$9.77M Sell
85,543
-21,068
-20% -$1.9M ﹤0.01% 1933
2024
Q2
$8.05M Buy
106,611
+90,929
+580% +$6.19M ﹤0.01% 2287
2024
Q1
$1.07M Sell
15,682
-54,246
-78% -$3.76M ﹤0.01% 5294
2023
Q4
$4.39M Buy
+69,928
New +$3.63M ﹤0.01% 3034
2023
Q3
Sell
-72,733
Closed -$3.63M 9179
2023
Q2
$3.63M Buy
72,733
+52,919
+267% +$2.51M ﹤0.01% 3203
2023
Q1
$743K Buy
19,814
+11,753
+146% +$499K ﹤0.01% 5601
2022
Q4
$387K Buy
+8,061
New +$316K ﹤0.01% 6594
2020
Q4
Sell
-8,028
Closed -$396K 7945
2020
Q3
$396K Sell
8,028
-5,352
-40% -$213K ﹤0.01% 5508
2020
Q2
$423K Buy
+13,380
New +$430K ﹤0.01% 5330

Other funds holding PCVX

Jane Street's PCVX Position: Q2 2026 in Review

Jane Street reduced its Vaxcyte (PCVX) stake by 97% in Q2 2026, selling an estimated $13.4M and leaving 6,401 shares worth $372K. The position accounts for ﹤0.01% of the portfolio, ranked #8703.

Jane Street first reported a position in PCVX in Q2 2020 and has held it in 16 quarters since. The position peaked at $24.5M in Q4 2024. 331 funds tracked by Wall St. Rank hold PCVX as of Q2 2026.

  • Jane Street held 6,401 shares of Vaxcyte worth $372K as of Q2 2026.
  • Jane Street sold 246,476 Vaxcyte shares in Q2 2026, an estimated $13.4M.
  • Vaxcyte made up ﹤0.01% of Jane Street's portfolio in Q2 2026, its #8703 holding.
  • Jane Street first reported a position in Vaxcyte in Q2 2020 and has held it in 16 quarters since.
  • Jane Street's Vaxcyte position peaked at $24.5M in Q4 2024.
  • 331 funds tracked by Wall St. Rank held Vaxcyte as of Q2 2026.

Based on Jane Street's 13F filing for Q2 2026, filed 14 Aug 2026.